By Katherine Hobson
It is directed objectives: - After a long parade month, Sanofi-Aventis Genzyme will buy for 74 cents a share, plus potential additional payments if the potential of biotechnology in Boston Multiple Sclerosis treatment from now Only - helped shape leukemia meets certain sales, the WSJ reported. The so-called contingent value right, "says a separate trading, paper, and payments could reach $ 14 per share if the drug meets all its objectives, the document said.
vaccines against influenza, formerly the production process of vaccines against influenza in animal cells instead of chicken eggs to incubate faster a virus is promising, reports the NYT. An article published in the Lancet shows that the vaccine formulated with Baxter, the method new method was about 70% effective against seasonal influenza vaccines prepared on a comparable basis with the old, the eggs, the paper said. It is not clear when Baxter seek FDA approval of new vaccine.
GDUFA Dates: In an effort to reduce the drug 2 1 / 2 years, it is now necessary for the FDA to gain general support by pharmaceutical companies are too generic Agency loans now pay user fees to a policy they even reported The Wall Street Journal cons. Businesses want a system with a single rate for both approvals and operation of inspection.
Malpractice Money: Obama in 2012, the proposal includes the fiscal year $ 250 million in grants for states to amend laws to prevent abuses, including health courts, provisions to encourage physicians and hospitals to detect errors and apologize and refuge laws for physicians following the guidelines, reports the Associated Press. Funds can not be used to establish caps on jury prize, says the AP.
Image: iStockphoto
0 komentar:
Posting Komentar